Burning Rock Biotech Limited
BNR
$8.83
-$0.46-4.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 59.81% | 59.81% |
| Total Depreciation and Amortization | -- | -- | -- | -60.76% | -60.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -58.12% | -58.12% |
| Total Other Non-Cash Items | -- | -- | -- | -54.95% | -54.95% |
| Change in Net Operating Assets | -- | -- | -- | 29.70% | 29.70% |
| Cash from Operations | -- | -- | -- | 59.28% | 59.28% |
| Capital Expenditure | -- | -- | -- | 32.88% | 32.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 1,775.86% | 1,775.86% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 5.37% | 5.37% |
| Cash from Investing | -- | -- | -- | 53.95% | 53.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 98.97% | 98.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 100.00% |
| Cash from Financing | -- | -- | -- | 99.85% | 99.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -57.42% | -57.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 67.67% | 67.67% |